Home
News
Create
Screeners
Insights
Krebs Biochemicals & Industries
66.
37
-0.75
(-1.12%)
Market Cap
₹143.10 Cr
PE Ratio
-5.27
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-1.12%
1M
-3.48%
6M
-12.91%
1Y
-20.13%
5Y
-21.87%
View Company Insights
Latest news about Krebs Biochemicals & Industries
Krebs Biochemicals Reports Rs 1,146.71 Lakh Loss for H1 2025, Revenue at Rs 1,977.70 Lakh
Nov 04, 2025
Krebs Biochemicals & Industries Limited announced unaudited financial results for H1 2025, showing a reduced loss before tax of Rs 1,146.71 lakh compared to Rs 2,093.20 lakh in the previous year. Revenue from operations was Rs 1,977.70 lakh. The company's cash position weakened with cash and cash equivalents at Rs 12.71 lakh. The Vizag manufacturing unit remains closed due to a pollution control board order. The company operates in a single business segment with no subsidiaries or joint ventures.
Krebs Biochemicals Reports Rs 532.43 Crore Loss in Q1, Appoints New MD & CEO
Aug 08, 2025
Krebs Biochemicals Appoints New MD & CEO, Announces Q1 Results
Aug 07, 2025
Krebs Biochemicals Announces Q1 Results and Leadership Transition
Aug 07, 2025
Krebs Biochemicals & Industries' MD & CEO Jitendra Shah Steps Down
Jul 25, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation